NanoViricides
NNVC
#10148
Rank
NZ$34.57 M
Marketcap
NZ$1.60
Share price
-3.50%
Change (1 day)
-23.70%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: NZ$34.57 Million

As of February 2026 NanoViricides has a market cap of NZ$34.57 Million. This makes NanoViricides the world's 10148th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$34.57 M-21.99%
2025NZ$44.31 M16.14%
2024NZ$38.15 M101.42%
2023NZ$18.94 M-6.66%
2022NZ$20.29 M-67.66%
2021NZ$62.76 M47.96%
2020NZ$42.42 M194.07%
2019NZ$14.42 M-30.39%
2018NZ$20.72 M-73.6%
2017NZ$78.48 M-12.7%
2016NZ$89.9 M-9.82%
2015NZ$99.69 M-49.23%
2014NZ$0.19 B-32.82%
2013NZ$0.29 B221.37%
2012NZ$90.95 M-22.08%
2011NZ$0.11 B-55.86%
2010NZ$0.26 B71.31%
2009NZ$0.15 B-9.87%
2008NZ$0.17 B182.32%
2007NZ$60.66 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of NanoViricides was reported to be:

NZ$34.57 Million
by Nasdaq info icon info icon
NZ$34.57 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$292.55 B 846,140.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$457.49 B 1,323,224.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$186.14 B 538,339.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$173.21 B 500,948.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.38 B 6,805.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$2.70 B 7,730.79%๐Ÿ‡บ๐Ÿ‡ธ USA